Skip to content

eSource Reduces Protocol Deviations Compared to Paper Source

Electronic Source Reduces Protocol Deviations

With nine locations in Texas, California and Louisiana, and five-time recipient of the Best Clinical Trials Site/Network award from the World Vaccine Congress, Benchmark Research is one of the industry’s leading vaccine network. This white paper provides an in-depth analysis from three participating Benchmark Research. Specifically, results indicate that using CRIO electronic source (eSource) reduces protocol deviations compared to traditional paper source (pSource) in clinical trials. The reduction rate was nearly 40%, demonstrating that the adoption of CRIO improves data quality and enhances patient safety. This improvement is attributed to CRIO’s system features, including real-time edit checks and automated error-detection processes.

Beyond reducing protocol deviations

CRIO’s impact extends beyond just minimizing protocol deviations. It also safeguards patient privacy, standardizes processes across data holders, delivers large data volumes, and enhances cost efficiency. Decreased protocol deviations result in fewer downstream effects, such as reduced data cleaning times and lower costs for corrective action plans. This efficiency could allow sponsors and study stakeholders to redirect resources into other areas of clinical research.

eSource vs paper

Further, CRIO eSource improves the quality assurance process compared to traditional pSource methods. With pSource, quality control personnel often need to scan, email, and annotate paper charts. This created delays between data capture and quality control. Conversely, with CRIO, the Quality Assurance team can review data shortly after its collection or even in real-time during an ongoing study visit. CRIO’s electronic system allows multiple stakeholders to simultaneously access data from various locations, thus streamlining global workflows.

What’s next?

CRIO offers a more efficient and reliable alternative to traditional pSource methods in clinical trials. By improving data quality, patient safety, recruitment, and stipend management for patients, CRIO enhances the overall experience for all involved parties.  Download the complete white paper to see the details of the analysis.

Related Reading: How the World’s Leading Vaccine Network Reduced Protocol Deviations by 40% Using eSource

CRIO favicon by Team CRIO
Share this white paper
You may also find interesting
Explore our White Papers & eBooks
Clinical Trial Site Mega Network eBook
1 Minute Read -

The Rise of the Clinical Trial Site Mega Network

Discover our latest eBook, “The Rise of the Clinical Trial Site Mega Network” the third installment in our “Scaling and Innovating” series. The first book in this series was published in 2019, where CRIO predicted that clinical research site networks would continue to grow and consolidate the industry. The second eBook, which was published in...

Health Information & Clinical Research Integration: The Challenge
1 Minute Read -

Health Information & Clinical Research Integration: The Challenge

In the past several decades, Electronic Health Record (EHR) systems have become the standard in documenting clinical care in the United States and many other countries, while Electronic Data Capture (EDC) systems have become standard in global pharmaceutical trials. Naturally, the industry has been highly focused on the tantalizing possibility of integrating EHR into EDC....

A Comparison of EMR and eSource in Clinical Research Trials
1 Minute Read -

A Comparison of EMR and eSource Data

In a comparison of EMR and eSource data, we analyzed the medications and medical history documented in the EMR versus the EDC of subjects in active ongoing clinical research studies. The goal was to assess the validity of the assumption of the utility of using EMR data directly. The present study reveals a significant data...

Get articles delivered to your inbox, every week